MedPlex Eixo Norte

Porto Alegre, Rio Grande do Sul 91010-004

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-Resistant Prostate Cancer, mCRPC

Studies at this site

• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling